Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Tulip Film coated tablets 40mg - HSA Drug Approval Details

Approvals/HSA/Tulip Film coated tablets 40mg

Approved

THERAPEUTIC

Tulip Film coated tablets 40mg

Lek Pharmaceuticals d.d. (Ljubljana site)Lek d.d., PE PROIZVODNJA LENDAVA (Primary and secondary packager)🇸🇬 Health Sciences Authority

Approval Date: Oct 18, 2012
Approval ID: f3f2a98da270a9b3
Company: Lek Pharmaceuticals d.d. (Ljubljana site)Lek d.d., PE PROIZVODNJA LENDAVA (Primary and secondary packager)
Type: Therapeutic

Approval Details

Approval Id: f3f2a98da270a9b3
Drug Name: Tulip Film coated tablets 40mg
Product Name: Tulip Film coated tablets 40mg
Approval Number: SIN14254P
Approval Date: 2012-10-18
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Licence Holder: SANDOZ SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: C10AA05
Atc Item Name: atorvastatin
Pharma Manufacturer Name: SANDOZ SINGAPORE PTE. LTD.
Company Detail Path: /organization/sandoz-singapore-pte-ltd

Active Ingredients

Atorvastatin calcium 41.361mg eqv. Atorvastatin

40.000 mg

ATORVASTATIN CALCIUM 41.361 MG EQV. ATORVASTATIN

40 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 18, 2012

Approval ID

f3f2a98da270a9b3

Type

Therapeutic

Back to HSA Approvals